Innovation Pharmaceuticals (IPIX) Financial Statements

Innovation Pharmaceuticals's market cap is currently $1.13M. The company's EPS TTM is $-0.005; its P/E ratio is ―; Innovation Pharmaceuticals is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.